期刊文献+

乳腺浸润性导管癌组织学分级与BAD、p-BAD及p-ERK蛋白的表达 被引量:2

Relationship between histological stages and expression of BAD,p-BAD and p-ERK protein in breast invasive ductal carcinoma
下载PDF
导出
摘要 目的:探讨乳腺浸润性导管癌不同组织学分级间BAD及其磷酸化形式p-BAD和上游作用因子ERK的活性形式p-ERK蛋白表达的变化。方法:应用免疫组化SP法检测83例乳腺浸润性导管癌中BAD、p-BAD及p-ERK蛋白表达及应用TUNEL法原位观察不同组织学分级间凋亡指数的差异。结果:组织学分级越高,凋亡指数及BAD、p-BAD及p-ERK蛋白表达均越高,且在高分化与低分化组间差异均具有统计学意义。BAD与凋亡指数存在正相关性(r=1.000,P=0.018),BAD与p-BAD存在正相关性(r=0.999,P=0.031),p-BAD与p-ERK存在正相关性(r=0.997,P=0.040)。结论:BAD、p-BAD及p-ERK在乳腺浸润性导管癌蛋白表达水平呈现出肿瘤分化级别越低而表达越强的特征,这与肿瘤恶性进程中细胞发生凋亡与增殖的变化有关。 Objective:To investigate the relationship between the histological stages and the expression of BAD,p-BAD,and p-extracellular signal-regulated kinase(ERK) protein in breast invasive ductal carcinoma. Methods:Expression of BAD, p-BAD, and p-ERK protein was assessed by immunohistochemical staining in 83 breast invasive ductal carcinoma tissues; apoptosis was assayed by quantitative TUNEL(Terminal Deoxynucleotidyl Transferase Biotin -dUTP Nick End Labeling) methods. Results: The lower the histological stages, the higher the expression of BAD, p-BAD, and p-ERK proteins and apoptotic index(At). The difference between histological stage Ⅰ and Ⅲ in the expression of the three proteins and apoptotic index was significant (P〈 0.05). A statistically significant positive linear relationship was found between BAD and AI(r= 1. 000, P 0.018), BAD and p- BAD(r=0. 999,P 0. 031) as well as p-BAD and p-ERK(r=0. 997,P=0. 040). Concluslon. Expressions of BAD,p-BAD,and p-ERK and Al were all associated with differentiation of breast invasive ductal carcinoma. BAD, p-BAD and p-ERK may be involved in the modulation of apoptosis and proliferation of breast cancer.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第3期267-270,共4页 Tumor
基金 辽宁省教育厅基金资助项目(编号:2004D107)
关键词 乳腺肿瘤 导管 乳腺 细胞凋亡 BAD蛋白 ERK蛋白 Breast neoplasms Carcinoma,ductal, breast Apoptosis BAD protein ERK protein
  • 相关文献

参考文献10

  • 1HAYAKAWA J,OHMICHI J, KURACHI H, et al. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin[J]. Cancer Res ,2000,60:5988-5994.
  • 2GILMORE A P, VA LENTIJN A J, WANG P, et al. Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transaetivation by insulinlike growth factor receptor[J], J Biol Chem ,2002,277:27643-27650.
  • 3ROBBINS D J, ZHEN E Z, OWAKI H, et al . Regulation and droperties of extraeellular signal regulated protein kinases 1 and 2 in vitro [J]. J Biol Chem ,1993,268:5097-5106.
  • 4BONNI A, BRUNET A, WEST A E, et al . Cell survival prorooted by the Ras MAPK signaling pathway by transcriptiondependent and independent mechanism [J]. Science , 1999,268 : 1358-1362.
  • 5LIPPONEN P,ALTOMAA S,KOSMA VM, et al. Apoptosis in breast cancer as related to histopathologieal characteristics and prognosis[J]. Fur J Cancer , 1994,14:2068-2073.
  • 6BERARDO M D, ELLEDGE R M, de MOOR C, et al . bel-2 and apoptosis in lymph node positive breast eareinoma [J].Cancer , 1998,82 : 1296-1302.
  • 7闫庆国,师建国,黄高昇,张传山,李青,胡沛臻,王文亮.肝外胆管癌组织BAG-1与BAD表达与凋亡调控的原位定量研究[J].世界华人消化杂志,2003,11(8):1144-1147. 被引量:3
  • 8KHOR T O,GUL Y A, ITHNIN H, et al . Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma[J]. Cancer Lett ,2004,210:139-150.
  • 9KOHLER T, SCHILL C, DEININGER M W, et al. High BAD and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia(AML) [J]. Leukemia , 2002,16:22-29.
  • 10HONG J R, WU J L. Induction of apoptotic death in cells via Bad gene expression by infectious pancreatic necrosis virus infection[J]. Cell Death Differ , 2002,9 : 113-124.

二级参考文献6

共引文献2

同被引文献29

  • 1苏建家,李瑗,班克臣,覃柳亮,王辉云,杨春,欧超,严瑞琪.动态研究HBV和AFB_1诱发树鼠句肝细胞癌过程中一些基因的表达[J].广西医科大学学报,2001,18(2):151-154. 被引量:8
  • 2王玉萍,曾宪旭,邵斌,楚天骄,雷冬梅.BAD、p-BAD及p-AKT蛋白在乳腺癌癌变过程中的表达及意义[J].山东医药,2007,47(5):63-65. 被引量:4
  • 3DAVIDO D J, RICHTER F, BOXBERGER F, et al. Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation[ J]. Eur J Cancer Prey,2001, 10(4) :313-321.
  • 4GIOELI D, MANDELL J W, PETRONI G R, et al. Activation of mitogen-activated protein kinase associated with prostate cancer progression [ J ]. Cancer Res, 1999,59 ( 2 ) :279-84.
  • 5FONG CW, CHUA MS, McKIE AB, et al. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma [ J ]. Cancer Res, 2006,66 ( 4 ) : 2048- 2058.
  • 6KLEIN P J, SCHMIDT C M, WIESENAUER C A, et al. The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer[ J ]. Neoplasia ,2006,8 ( 1 ) :1-8.
  • 7DAVIS R J. The mitogen-activated protein kinase signal transduction pathway [ J ]. J Biol Chem, 1993,268 ( 20 ) : 14553-14556.
  • 8BOULTON T G, NYE S H, ROBBINS D J, et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF[ J]. Cell, 1991,65 (4) :663-675.
  • 9HUYNH H, NGUYEN TT, CHOW KH, et al. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)- MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis [ J ]. BMC Gastroenterol,2003,3 : 19.
  • 10SANTEN R J, SONG RX, McPHERSON R, et al. The role of mitogen-activated protein (MAP) kinase in breast cancer [ J]. J Steroid Biochem Mol Biol,2002,80 (2) :239-256.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部